Andreas Eger
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer Cells and Metastasis
Papers in
-
- Wnt/β-catenin signaling in development and cancer 8
- Cancer-related gene regulation 4
- Oncology 14
- Cancer Cells and Metastasis 11
- Co-authors
- Roland Foisner (10 shared papers)Hartmut Beug (9 shared papers)Andreas Stockinger (4 shared papers)Thomas Brabletz (5 shared papers)Geert Berx (2 shared papers)Wolfgang Mikulits (7 shared papers)Martin Schreiber (5 shared papers)Brigitta Dampier (4 shared papers)
In The Last Decade
Andreas Eger
31 papers receiving 3.5k citations
Andreas Eger's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 833
- Oncology 1.4k
- Molecular Biology 2.3k
- Cell Biology 488
- Immunology and Allergy 119
Countries citing papers authored by Andreas Eger
This map shows the geographic impact of Andreas Eger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Eger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Eger more than expected).
Fields of papers citing papers by Andreas Eger
This network shows the impact of papers produced by Andreas Eger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Eger. The network helps show where Andreas Eger may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Eger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells Hit paper breakdown → | 2005 | 658 |
| 2 | 2007 | 495 | |
| 3 | 2008 | 426 | |
| 4 | 2006 | 407 | |
| 5 | 2001 | 281 | |
| 6 | 2003 | 266 | |
| 7 | 2000 | 172 | |
| 8 | 2004 | 128 | |
| 9 | 2014 | 117 | |
| 10 | 2007 | 80 | |
| 11 | 1997 | 65 | |
| 12 | 2006 | 60 | |
| 13 | 2010 | 58 | |
| 14 | 2014 | 43 | |
| 15 | 2014 | 42 | |
| 16 | The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression | 2007 | 41 |
| 17 | 2005 | 33 | |
| 18 | 2017 | 33 | |
| 19 | 2013 | 32 | |
| 20 | 2005 | 29 |
About Andreas Eger
Andreas Eger is a scholar working on Molecular Biology, Oncology, Cell Biology, Genetics and Immunology, having authored 31 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Wnt/β-catenin signaling in development and cancer (8 papers), Cancer-related gene regulation (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers), Digestive system and related health (3 papers), Skin and Cellular Biology Research (2 papers), 3D Printing in Biomedical Research (2 papers) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Cancer Research (833 citations), Oncology (1.4k citations), Molecular Biology (2.3k citations), Cell Biology (488 citations) and Immunology and Allergy (119 citations). Andreas Eger has collaborated with scholars based in Austria, Germany and Belgium. Frequent co-authors include Roland Foisner, Hartmut Beug, Andreas Stockinger, Thomas Brabletz, Geert Berx, Wolfgang Mikulits, Martin Schreiber, Brigitta Dampier, Mario Mikula and Falk Hlubek. Their work appears in journals such as Oncogene, PLoS ONE, SLAS DISCOVERY, The Journal of Cell Biology and Electrophoresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.